Search

Author/Creator Ghiringhelli, F

2. 614TiPUCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis. (23rd October 2018)

Authors:
Mazard, T; Ghiringhelli, F; Mollevi, C; Assenat, E; Gavoille, C; Smith, D; Pezzella, V; Meddeb, R; Pastor, B; Ychou, M; Thierry, A R
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants. (29th March 2019)

Authors:
Messaoudene, M; Mourikis, T P; Michels, J; Fu, Y; Bonvalet, M; Lacroix-Trikki, M; Routy, B; Fluckiger, A; Rusakiewicz, S; Roberti, M P; Cotteret, S; Flament, C; Poirier-Colame, V; Jacquelot, N; Ghiringhelli, F; Caignard, A; Eggermont, A M M; Kroemer, G; Marabelle, A; Arnedos, M
Journal:
Annals of oncology
Issue:
Volume 30:Number 6(2019)
Page Start:
934
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗